Diabetes and obesity are the main metabolic drivers of peripheral neuropathy

2. Classification and Diagnosis of Diabetes

(2016)   DIABETES CARE

Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

(2016) Brian C. Callaghan et al.   DIABETES CARE

Diabetic Neuropathy: A Position Statement by the American Diabetes Association

(2016) Rodica Pop-Busui et al.   DIABETES CARE

Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study

(2016) Rens Hanewinckel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Prevalence of polyneuropathy in the general middle-aged and elderly population

(2016) Rens Hanewinckel et al.   NEUROLOGY

Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population

(2016) Brian C. Callaghan et al.   JAMA Neurology

Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort

(2015) C. Christine Lee et al.   DIABETES CARE

Distal Symmetric Polyneuropathy

(2015) Brian C. Callaghan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome

(2015) Ling Han et al.   Diabetology & Metabolic Syndrome

Role of Neurologists and Diagnostic Tests on the Management of Distal Symmetric Polyneuropathy

(2014) Brian C. Callaghan et al.   JAMA Neurology

Determination of Peripheral Neuropathy Prevalence and Associated Factors in Chinese Subjects with Diabetes and Pre-Diabetes – ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH-DREAMS)

(2013) Bin Lu et al.   PLoS One

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

(2012) W. H. Herman et al.   DIABETIC MEDICINE

Peripheral Vascular Disease and Peripheral Neuropathy in Individuals With Cardiometabolic Clustering and Obesity: National Health and Nutrition Examination Survey 2001-2004

(2011) K. R. Ylitalo et al.   DIABETES CARE

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

(2010) Faramarz Ismail-Beigi et al.   LANCET

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics

(2009) K. Van Acker et al.   DIABETES & METABOLISM